Can unscheduled inpatient length of stay and hospital costs be reduced using 'flash' glucose monitoring?

Phase 2

Completed

• Conditions: Diabetes mellitus; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN11565460
• Lead Sponsor: niversity of the Highlands and Islands

Brief Summary

2021 Results article in https://doi.org/10.1111/dme.14753 (added 10/05/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-11-10
• Study Completion: 2022-01-31
• Last Update Posted: 23 May 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Phase 2, Part B: pilot study – use of Flash Glucose Monitoring:
1. Adults (aged 18 years and older)
2. Diagnosed with diabetes
3. Admitted to hospital wards defined in phase 1
4. Able to read and understand the participant information sheet (PIS)
5. Able to give written informed consent

Phase 2, Part C: pilot study - evaluation interviews:
1. Patients or HCPs that have participated in phase 2, part B
2. Able to read and understand the participant information sheet (PIS)
3. Able to give written informed consent

Exclusion Criteria

Phase 2, Part B: pilot study - use of flash glucose monitoring:
1. Children or young people (aged younger than 18 years)
2. Not diagnosed with diabetes
3. Admitted to hospital wards not defined in phase 1
4. Pregnancy or gestational diabetes
5. Significant intercurrent illness and/or terminal diagnosis
6. Have a condition and/or treatment known to affect variability of blood glucose, such as on kidney dialysis
7. Already using a Flash Glucose Monitoring or continuous monitoring device
8. Unable to read and understand the participant information sheet (PIS)
9. Unable to give written informed consent

Phase 2, Part C: pilot study - evaluation interviews:
1. Ongoing significant co-morbid illness
2. Unable to read and understand the participant information sheet

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Clinical decision making (changes made to therapy) measured using patient medical records at 4 hourly intervals<br> 2. Patient safety measured using patient medical records at 4 hourly intervals<br>

Secondary Outcome Measures

Name	Time	Method
ength of stay (LoS) measured using patient medical records at hospital discharge